Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
doi:10.1378/chest.06-2485
(Chest. 2007; 131:657-663)
© 2007 American College of Chest Physicians
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathan, S. D.
Right arrow Articles by Barnett, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathan, S. D.
Right arrow Articles by Barnett, S. D.
Related Content
Right arrowRelated Articles
Right arrowRelated Editorial

Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis*

Steven D. Nathan, MD, FCCP; Oksana A. Shlobin, MD; Shahzad Ahmad, MD; Susan Urbanek, RN and Scott D. Barnett, PhD

* From Inova Fairfax Hospital, Falls Church, VA.

Correspondence to: Steven D. Nathan, MD, FCCP, Medical Director, Lung Transplant Program, Inova Heart & Vascular Institute, Inova Fairfax Hospital, 3300 Gallows Rd, Falls Church, VA 22042; e-mail: steven.nathan{at}inova.com

Abstract

Background: Pulmonary hypertension (PH) is commonly seen in patients with idiopathic pulmonary fibrosis (IPF). We sought to examine the relationship between pulmonary function tests (PFTs), including the percentage of predicted FVC (FVC%), percentage of predicted total lung capacity, percentage of predicted diffusing capacity of the lung for carbon monoxide (DLCO%), the composite physiologic index (CPI), and PH. The ability of FVC%, DLCO%, and FVC%/DLCO% ratio to predict underlying PH was assessed.

Methods: Retrospective review of IPF patients seen at a tertiary referral center over an 8-year interval in whom both PFT and right-heart catheterization data were available.

Results: The study cohort consisted of 118 patients, of whom 48 patients (40.7%) had PH. There was no correlation between measures of lung volumes or the CPI with underlying PH. There was a modest association between DLCO% and PH, with DLCO% < 30 having a twofold-higher prevalence of PH (56.4%) compared to DLCO% ≥ 30 (28.6%). Cardiac dysfunction might have played a small role, since 16.1% of the patients had an associated elevated pulmonary capillary wedge pressure. There was a trend to a higher prevalence and greater severity of PH in those patients with FVC% > 70 compared to the group with FVC% < 40.

Conclusion: PH is common in patients with IPF. There is a poor correlation between lung function measures and PH, suggesting that factors other than fibrosis may play a role in the etiology. The unexpected high prevalence and severity of PH in patients with well-maintained lung function have implications for the prognosis and management of the disease.

Key Words: hypertension • pulmonary • pulmonary fibrosis • pulmonary function tests


Related Articles

Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
Kunio Hamada, Sonoko Nagai, Shigeru Tanaka, Tomohiro Handa, Michio Shigematsu, Taishi Nagao, Michiaki Mishima, Masanori Kitaichi, and Takateru Izumi
Chest 2007 131: 650-656. [Abstract] [Full Text] [PDF]

Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
Harold R. Collard, Kevin J. Anstrom, Marvin I. Schwarz, and David A. Zisman
Chest 2007 131: 897-899. [Abstract] [Full Text] [PDF]

Related Editorial

The Impact of Pulmonary Arterial Hypertension on Idiopathic Pulmonary Fibrosis
Charlene D. Fell and Fernando J. Martinez
Chest 2007 131: 641-643. [Full Text] [PDF]



This article has been cited by other articles:


Home page
ChestHome page
D. A. Zisman, A. S. Karlamangla, S. M. Kawut, O. A. Shlobin, R. Saggar, D. J. Ross, M. I. Schwarz, J. A. Belperio, A. Ardehali, J. P. Lynch III, et al.
Validation of a Method To Screen for Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest, March 1, 2008; 133(3): 640 - 645.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation, December 18, 2007; 116(25): 2992 - 3005.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. M. Patel, D. J. Lederer, A. C. Borczuk, and S. M. Kawut
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Chest, September 1, 2007; 132(3): 998 - 1006.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. A. Zisman, A. S. Karlamangla, D. J. Ross, M. P. Keane, J. A. Belperio, R. Saggar, J. P. Lynch III, A. Ardehali, and J. Goldin
High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest, September 1, 2007; 132(3): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. D. Fell and F. J. Martinez
The Impact of Pulmonary Arterial Hypertension on Idiopathic Pulmonary Fibrosis
Chest, March 1, 2007; 131(3): 641 - 643.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.